These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1131390)

  • 1. The rapid identification of a new metabolite of warfarin via a chemical ionization mass spectrometry ion doublet technique.
    Pohl LR; Nelson SD; Garland WA; Trager WF
    Biomed Mass Spectrom; 1975 Feb; 2(1):23-30. PubMed ID: 1131390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrate probes for the mechanism of aromatic hydroxylation catalyzed by cytochrome P-450: selectively deuterated analogues of warfarin.
    Bush ED; Trager WF
    J Med Chem; 1985 Aug; 28(8):992-6. PubMed ID: 4020838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative liquid chromatography/mass spectrometry/mass spectrometry warfarin assay for in vitro cytochrome P450 studies.
    Zhang ZY; King BM; Wong YN
    Anal Biochem; 2001 Nov; 298(1):40-9. PubMed ID: 11673893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical synthesis, absolute configuration, and stereochemistry of formation of 10-hydroxywarfarin: a major oxidative metabolite of (+)-(R)-warfarin from hepatic microsomal preparations.
    Lawrence RF; Rettie AE; Eddy AC; Trager WF
    Chirality; 1990; 2(2):96-105. PubMed ID: 2400642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of (R)-8-hydroxywarfarin in human liver microsomes. A new metabolic marker for the (S)-mephenytoin hydroxylase, P4502C19.
    Wienkers LC; Wurden CJ; Storch E; Kunze KL; Rettie AE; Trager WF
    Drug Metab Dispos; 1996 May; 24(5):610-4. PubMed ID: 8723744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Warfarin: stereochemical aspects of its metabolism in vivo in the rat.
    Pohl LR; Bales R; Trager WF
    Res Commun Chem Pathol Pharmacol; 1976 Oct; 15(2):233-56. PubMed ID: 981784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regioselectivity significantly impacts microsomal glucuronidation efficiency of R/S-6, 7-, and 8-hydroxywarfarin.
    Kim SY; Jones DR; Kang JY; Yun CH; Miller GP
    Xenobiotica; 2019 Apr; 49(4):397-403. PubMed ID: 29543105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions.
    Rettie AE; Korzekwa KR; Kunze KL; Lawrence RF; Eddy AC; Aoyama T; Gelboin HV; Gonzalez FJ; Trager WF
    Chem Res Toxicol; 1992; 5(1):54-9. PubMed ID: 1581537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of oxidative warfarin metabolites by thermospray high-performance liquid chromatography/mass spectrometry.
    Spink DC; Aldous KM; Kaminsky LS
    Anal Biochem; 1989 Mar; 177(2):307-13. PubMed ID: 2729550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbial models of mammalian metabolism: production of 3'-hydroxywarfarin, a new metabolite of warfarin using Cunninghamella elegans.
    Wong YW; Davis PJ
    J Pharm Sci; 1991 Apr; 80(4):305-8. PubMed ID: 1865328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mechanism of the warfarin-rifampin drug interaction in humans.
    Heimark LD; Gibaldi M; Trager WF; O'Reilly RA; Goulart DA
    Clin Pharmacol Ther; 1987 Oct; 42(4):388-94. PubMed ID: 3665337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial models of mammalian metabolism: conversion of warfarin to 4'-hydroxywarfarin using Cunninghamella bainieri.
    Rizzo JD; Davis PJ
    J Pharm Sci; 1989 Mar; 78(3):183-9. PubMed ID: 2724074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The deuterium isotope effect for the alpha-hydroxylation of tamoxifen by rat liver microsomes accounts for the reduced genotoxicity of [D5-ethyl]tamoxifen.
    Jarman M; Poon GK; Rowlands MG; Grimshaw RM; Horton MN; Potter GA; McCague R
    Carcinogenesis; 1995 Apr; 16(4):683-8. PubMed ID: 7728943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of (S)-warfarin metabolism by sulfinpyrazone and its metabolites.
    He M; Kunze KL; Trager WF
    Drug Metab Dispos; 1995 Jun; 23(6):659-63. PubMed ID: 7587949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid chromatography-mass spectrometry and gas chromatography-mass spectrometry of omega- and (omega-1)-hydroxylated metabolites of elaidic and oleic acids in human and rat liver microsomes.
    Adas F; Picart D; Berthou F; Simon B; Amet Y
    J Chromatogr B Biomed Sci Appl; 1998 Sep; 714(2):133-44. PubMed ID: 9766853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanism of the interaction between amiodarone and warfarin in humans.
    Heimark LD; Wienkers L; Kunze K; Gibaldi M; Eddy AC; Trager WF; O'Reilly RA; Goulart DA
    Clin Pharmacol Ther; 1992 Apr; 51(4):398-407. PubMed ID: 1563209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new warfarin metabolite: structure and function.
    Fasco MJ; Dymerski PP; Wos JD; Kaminsky LS
    J Med Chem; 1978 Oct; 21(10):1054-9. PubMed ID: 722713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of bambuterol in rat liver microsomes: identification of hydroxylated and demethylated products by liquid chromatography mass spectrometry.
    Lindberg C; Roos C; Tunek A; Svensson LA
    Drug Metab Dispos; 1989; 17(3):311-22. PubMed ID: 2568914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of glimepiride and glibenclamide on S-warfarin 7-hydroxylation by human liver microsomes, recombinant human CYP2C9.1 and CYP2C9.3.
    Iwakawa S; Miyashita K; Hashimoto Y; Kuroda T
    Biol Pharm Bull; 2006 Sep; 29(9):1983-5. PubMed ID: 16946524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human hepatic cytochrome P-450 composition as probed by in vitro microsomal metabolism of warfarin.
    Kaminsky LS; Dunbar DA; Wang PP; Beaune P; Larrey D; Guengerich FP; Schnellmann RG; Sipes IG
    Drug Metab Dispos; 1984; 12(4):470-7. PubMed ID: 6148215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.